Lonza launches Engine equipment range

Published: 11-Jun-2019

New offering by the Swiss CDMO is a comprehensive technical service platform for small molecule formulation and dosage forms

Lonza Engine is the latest addition to the Swiss CDMO offering to the pharmaceutical industry. Engine by Lonza is a comprehensive technical service platform that includes the equipment portfolio of the legacy Capsugel and Micromacinazione companies.

The new offering is designed to address the needs of customers throughout the entire small molecule drug development process.

Christian Dowdeswell, VP and Head of BU Dosage Forms & Delivery Systems, Lonza Pharma & Biotech, explained: "Lonza offers a powerful range of world-class industrial equipment that has earned the trust of our customers, who can rely on our proven technology: we know it works because we use it first."

Micronisation equipment Pilot line – MC100

Micronisation equipment Pilot line – MC100

Dowdeswell said Lonza's equipment is backed by a global network of business and technical support services designed to help customers to get the most out of their production process.

Support bioavailability enhancement

The Lonza Engine equipment portfolio has been created to support bioavailability enhancement, encapsulation and early-phase clinical development technologies.

The portfolio offers state-of-the-art machines including micronisation, capsule filling and sealing, and powder micro-dosing equipment.

The Xcelodose powder micro-dosing system within the portfolio provides highly consistent dose accuracy by precise filling of capsules without excipients or bulking agents.

Detail: Micronisation equipment Lab line – MC44

Detail: Micronisation equipment Lab line – MC44

The capsule filling and sealing (CFS) equipment provides support for lipid-based formulations to improve the bioavailability of poorly soluble compounds.

In addition, thanks to the micronisation equipment, the desired particle size distribution of the drug substance can be reached in order to improve the drug product performance.

"The new equipment portfolio complements our offerings for the pharma and consumer health and nutrition industries and supports our goal to serve markets along the Healthcare Continuum," said Fabio Invernizzi, VP Global Sales, Capsule Delivery Solutions, Lonza Pharma & Biotech.

The addition of the Lonza Engine offering broadens Lonza's already comprehensive equipment portfolio for capsule filling, now providing solutions for the entire drug product development process.

You may also like